I. Ntafoulis

Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma

M. Lamfers, S. Leenstra, S. Koolen, 2022, Cancers.

Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures

M. Lamfers, S. Leenstra, C. Páyan-Gomez, 2021, Neuro-oncology advances.

Generation, characterization and drug sensitivities of twelve patient-derived IDH1 mutant glioma cell cultures

M. Lamfers, S. Leenstra, C. Páyan-Gomez, 2021, bioRxiv.

Identification, validation and biological characterization of novel Glioblastoma Tumour Microenvironment subtypes: Implications for precision immunotherapy.

R. Verhaak, P. Wen, M. Lamfers, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

M. J. van den Bent, D. Lambrechts, A. Kleijn, 2023, British Journal of Cancer.

Identification of inter- and intra-tumoral molecular phenotypes steering temozolomide resistance in patient-derived glioblastoma cells

D. Lambrechts, M. Lamfers, S. Leenstra, 2023, bioRxiv.

Comparative analysis of deeply phenotyped GBM cohorts of ‘short-term’ and ‘long-term’ survivors

D. Lambrechts, M. Lamfers, S. Leenstra, 2023, Journal of Neuro-Oncology.

Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells

D. Lambrechts, M. Lamfers, S. Leenstra, 2023, International journal of molecular sciences.

Identification, validation and biological characterization of novel Glioblastoma Tumour Microenvironment subtypes: Implications for precision immunotherapy.

A. Idbaih, C. Sautès-Fridman, A. Bougoüin, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.